| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,650 |
15,110 |
$961K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,458 |
5,241 |
$825K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,911 |
10,020 |
$557K |
| 80053 |
Comprehensive metabolic panel |
12,172 |
9,445 |
$311K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,535 |
2,809 |
$288K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,216 |
2,794 |
$210K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,396 |
3,002 |
$200K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,184 |
7,260 |
$185K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,515 |
2,052 |
$175K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,583 |
2,924 |
$159K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,763 |
1,536 |
$120K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,981 |
14,361 |
$110K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
981 |
891 |
$102K |
| G0378 |
Hospital observation service, per hour |
2,913 |
2,406 |
$97K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
939 |
589 |
$91K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,517 |
1,289 |
$88K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,326 |
2,137 |
$76K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,703 |
5,140 |
$75K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,014 |
1,306 |
$59K |
| 85610 |
|
4,693 |
3,305 |
$56K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
690 |
629 |
$47K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,963 |
1,839 |
$46K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
694 |
612 |
$46K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,062 |
907 |
$45K |
| 84484 |
|
6,319 |
3,470 |
$45K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,826 |
5,111 |
$43K |
| 81025 |
|
4,259 |
3,577 |
$41K |
| 87081 |
|
2,697 |
2,536 |
$34K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
353 |
319 |
$32K |
| 83880 |
|
1,453 |
1,263 |
$29K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
483 |
416 |
$28K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
492 |
272 |
$28K |
| 87070 |
|
2,682 |
2,439 |
$26K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
264 |
241 |
$25K |
| 83735 |
|
5,480 |
4,001 |
$24K |
| 83690 |
|
4,572 |
3,742 |
$24K |
| 84702 |
|
1,653 |
1,049 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
3,277 |
2,968 |
$23K |
| 80143 |
|
1,420 |
1,141 |
$19K |
| 82962 |
|
3,385 |
1,954 |
$19K |
| 87077 |
|
2,407 |
2,155 |
$18K |
| 81001 |
|
5,677 |
4,851 |
$18K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
343 |
308 |
$16K |
| 82077 |
|
1,624 |
1,328 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,193 |
1,016 |
$16K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
863 |
763 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
420 |
368 |
$15K |
| 85027 |
|
3,155 |
2,445 |
$15K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
777 |
692 |
$15K |
| 80179 |
|
1,383 |
1,128 |
$15K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
351 |
277 |
$13K |
| 87186 |
|
2,159 |
1,881 |
$13K |
| 80076 |
|
1,982 |
1,707 |
$13K |
| 82728 |
|
1,094 |
976 |
$12K |
| 82607 |
|
832 |
756 |
$11K |
| 83605 |
|
1,421 |
1,149 |
$11K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
314 |
159 |
$10K |
| 87205 |
|
2,698 |
2,452 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
276 |
195 |
$10K |
| 85379 |
|
1,292 |
1,160 |
$10K |
| 76830 |
Ultrasound, transvaginal |
261 |
235 |
$9K |
| 84439 |
|
1,198 |
1,035 |
$9K |
| 96367 |
|
162 |
83 |
$9K |
| 81003 |
|
1,859 |
1,638 |
$8K |
| 87400 |
|
196 |
178 |
$8K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
300 |
260 |
$8K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
308 |
291 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,384 |
7,315 |
$5K |
| 87040 |
|
779 |
366 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
92 |
77 |
$5K |
| 82805 |
|
248 |
196 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
105 |
80 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,076 |
681 |
$4K |
| 87210 |
|
721 |
647 |
$4K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
57 |
51 |
$4K |
| 80050 |
General health panel |
190 |
177 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,745 |
2,063 |
$3K |
| 87147 |
|
670 |
610 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
62 |
46 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
4,676 |
4,065 |
$3K |
| 84100 |
|
840 |
599 |
$3K |
| 76642 |
|
56 |
52 |
$2K |
| 76801 |
|
52 |
39 |
$2K |
| 77065 |
Tomosynthesis, mammo |
80 |
69 |
$2K |
| 74018 |
|
129 |
115 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,889 |
7,351 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
43 |
39 |
$2K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
30 |
27 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
117 |
109 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
35 |
26 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
17 |
14 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
62 |
55 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,995 |
5,163 |
$2K |
| 74183 |
|
21 |
12 |
$1K |
| 80061 |
Lipid panel |
79 |
76 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
80 |
64 |
$889.64 |
| 86850 |
|
173 |
148 |
$801.73 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
31 |
27 |
$797.50 |
| 83615 |
|
235 |
159 |
$776.98 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
26 |
24 |
$740.49 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
26 |
24 |
$740.49 |
| 84145 |
|
45 |
40 |
$707.07 |
| 93971 |
|
35 |
28 |
$673.14 |
| 70498 |
|
12 |
12 |
$659.63 |
| 82746 |
|
56 |
51 |
$622.73 |
| 86900 |
|
312 |
261 |
$609.83 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,216 |
4,397 |
$546.78 |
| 83970 |
|
15 |
14 |
$545.01 |
| 95806 |
|
89 |
81 |
$536.70 |
| 86901 |
|
251 |
213 |
$496.92 |
| Q3014 |
Telehealth originating site facility fee |
15 |
12 |
$449.80 |
| 84703 |
|
72 |
68 |
$448.56 |
| 86140 |
|
117 |
98 |
$433.31 |
| 73630 |
|
58 |
54 |
$373.33 |
| 94060 |
|
13 |
12 |
$373.27 |
| 82565 |
|
100 |
78 |
$367.38 |
| 85730 |
|
97 |
88 |
$325.30 |
| 88304 |
|
43 |
38 |
$311.76 |
| 77066 |
Tomosynthesis, mammo |
26 |
25 |
$302.61 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,221 |
4,075 |
$265.31 |
| 90715 |
|
49 |
38 |
$253.56 |
| 87899 |
|
13 |
12 |
$251.31 |
| 87106 |
|
30 |
24 |
$238.40 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$236.82 |
| 82570 |
|
50 |
26 |
$234.64 |
| 36415 |
Collection of venous blood by venipuncture |
3,134 |
2,128 |
$179.91 |
| 77061 |
|
28 |
25 |
$175.24 |
| 84550 |
|
58 |
48 |
$174.73 |
| 0352U |
|
62 |
54 |
$161.00 |
| 73130 |
|
72 |
62 |
$160.06 |
| 71250 |
|
13 |
12 |
$156.47 |
| 72131 |
|
21 |
14 |
$154.52 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,911 |
1,955 |
$134.09 |
| 83540 |
|
26 |
25 |
$133.81 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$119.92 |
| 82550 |
|
27 |
24 |
$116.35 |
| 96376 |
|
2,833 |
1,894 |
$113.61 |
| 73560 |
|
122 |
106 |
$99.18 |
| 36416 |
|
3,078 |
1,982 |
$94.59 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$90.63 |
| 83550 |
|
13 |
12 |
$86.69 |
| 73110 |
|
31 |
24 |
$76.45 |
| 85652 |
|
47 |
37 |
$74.44 |
| 36591 |
|
323 |
160 |
$72.34 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
957 |
615 |
$71.09 |
| J2060 |
Injection, lorazepam, 2 mg |
769 |
623 |
$60.65 |
| 84156 |
|
20 |
14 |
$60.37 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,174 |
4,790 |
$51.02 |
| 77062 |
|
12 |
12 |
$46.25 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,492 |
521 |
$10.94 |
| J2704 |
Injection, propofol, 10 mg |
1,430 |
1,058 |
$8.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,195 |
1,702 |
$7.20 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
313 |
235 |
$2.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
881 |
618 |
$2.46 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,488 |
1,331 |
$2.02 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
855 |
692 |
$0.83 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,805 |
1,388 |
$0.82 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,659 |
2,332 |
$0.73 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
181 |
153 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
925 |
750 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
297 |
249 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
318 |
200 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
55 |
38 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
50 |
39 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
35 |
26 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
48 |
40 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
30 |
25 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
671 |
523 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
468 |
354 |
$0.00 |
| 73610 |
|
32 |
25 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
59 |
24 |
$0.00 |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
155 |
132 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
19 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
100 |
73 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
56 |
36 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
12 |
$0.00 |
| 73030 |
|
15 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
12 |
$0.00 |